CLDN3 and prostate carcinoma: In this line, our data show that the loss of CLDN3 expression could be preventing cell–cell interactions favoring cell invasion, thus suggesting that the more aggressive phenotype of androgen-independent prostate cancer cells could be explained, at least in part, by CLDN3 epigenetic silencing.